Literature DB >> 16361023

Mechanisms of brain injury after intracerebral haemorrhage.

Guohua Xi1, Richard F Keep, Julian T Hoff.   

Abstract

The past decade has resulted in a rapid increase in knowledge of mechanisms underlying brain injury induced by intracerebral haemorrhage (ICH). Animal studies have suggested roles for clot-derived factors and the initial physical trauma and mass effect as a result of haemorrhage. The coagulation cascade (especially thrombin), haemoglobin breakdown products, and inflammation all play a part in ICH-induced injury and could provide new therapeutic targets. Human imaging has shown that many ICH continue to expand after the initial ictus. Rebleeding soon after the initial haemorrhage is common and forms the basis of a current clinical trial using factor VIIa to prevent rebleeding. However, questions about mechanisms of injuries remain. There are conflicting data on the role of ischaemia in ICH and there is uncertainty over the role of clot removal in ICH therapy. The next decade should bring further information about the underlying mechanisms of ICH-induced brain injury and new therapeutic interventions for this severe form of stroke. This review addresses our current understanding of the mechanisms underlying ICH-induced brain injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16361023     DOI: 10.1016/S1474-4422(05)70283-0

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  528 in total

1.  Proteasome Inhibitor Reduces Astrocytic iNOS Expression and Functional Deficit after Experimental Intracerebral Hemorrhage in Rats.

Authors:  Fahmi M Al-Senani; Xiurong Zhao; James C Grotta; Ali Shirzadi; Roger Strong; Jaroslaw Aronowski
Journal:  Transl Stroke Res       Date:  2011-10-19       Impact factor: 6.829

2.  Micro-computed tomography for hemorrhage disruption of mouse brain vasculature.

Authors:  Bohua Xie; Peng Miao; Yuhao Sun; Yongting Wang; Guo-Yuan Yang
Journal:  Transl Stroke Res       Date:  2012-04-18       Impact factor: 6.829

3.  Astrogliosis: a target for intervention in intracerebral hemorrhage?

Authors:  Sangeetha Sukumari-Ramesh; Cargill H Alleyne; Krishnan M Dhandapani
Journal:  Transl Stroke Res       Date:  2012-04-14       Impact factor: 6.829

4.  Hydrocephalus after intraventricular hemorrhage: the role of thrombin.

Authors:  Feng Gao; Fuyi Liu; Zhi Chen; Ya Hua; Richard F Keep; Guohua Xi
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-11       Impact factor: 6.200

5.  The Molecular Mechanisms that Promote Edema After Intracerebral Hemorrhage.

Authors:  Daniel Bodmer; Kerry A Vaughan; Brad E Zacharia; Zachary L Hickman; E Sander Connolly
Journal:  Transl Stroke Res       Date:  2012-04-12       Impact factor: 6.829

6.  Thrombin-induced cerebral hemorrhage: role of protease-activated receptor-1.

Authors:  Yingying Cheng; Guohua Xi; Hang Jin; Richard F Keep; Jiachun Feng; Ya Hua
Journal:  Transl Stroke Res       Date:  2013-09-21       Impact factor: 6.829

7.  Do current animal models of intracerebral hemorrhage mirror the human pathology?

Authors:  Opeolu Adeoye; Joseph F Clark; Pooja Khatri; Kenneth R Wagner; Mario Zuccarello; Gail J Pyne-Geithman
Journal:  Transl Stroke Res       Date:  2010-08-10       Impact factor: 6.829

8.  Depletion of GR-1-Positive Cells Is Associated with Reduced Neutrophil Inflammation and Astrocyte Reactivity after Experimental Intracerebral Hemorrhage.

Authors:  Matthew C Loftspring; Holly L Johnson; Aaron J Johnson; Joseph F Clark
Journal:  Transl Stroke Res       Date:  2012-05-02       Impact factor: 6.829

9.  Transplantation of neural stem cells that overexpress SOD1 enhances amelioration of intracerebral hemorrhage in mice.

Authors:  Takuma Wakai; Hiroyuki Sakata; Purnima Narasimhan; Hideyuki Yoshioka; Hiroyuki Kinouchi; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-11       Impact factor: 6.200

10.  Chemokines and their receptors in intracerebral hemorrhage.

Authors:  Yao Yao; Stella E Tsirka
Journal:  Transl Stroke Res       Date:  2012-04-03       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.